The effect of the usptsf psa guidelines on prostate cancer detection and mortality in two underserved cities in new jersey

You have accessJournal of UrologyCME1 Apr 2023MP12-04 THE EFFECT OF THE USPTSF PSA GUIDELINES ON PROSTATE CANCER DETECTION AND MORTALITY IN TWO UNDERSERVED CITIES IN NEW JERSEY Thomas Hwang, David Ali, Gabriel Fernandez, Courtney Berg, Evan Kovac, Amjad Alwaal, and Robert Weiss Thomas HwangThomas Hwang More articles by this author , David AliDavid Ali More articles by this author , Gabriel FernandezGabriel Fernandez More articles by this author , Courtney BergCourtney Berg More articles by this author , Evan KovacEvan Kovac More articles by this author , Amjad AlwaalAmjad Alwaal More articles by this author , and Robert WeissRobert Weiss More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003227.04AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: NJ has one of the most ethically and racially diverse populations in the United States. There are nine million people in NJ – 56% White, 20% Hispanic, 13% African American (AA) and 9% Asian. Despite this diversity, the discriminatory practice of “redlining” which withheld services and investment from specific neighborhoods has resulted in significant segregation in several NJ cities. Two urban centers in NJ – Newark and Trenton are examples of this segregation. Newark has a population of 318,431 with 50.8% AA, 34.8% Hispanic, 11.1% White and 1.8% Asian. Trenton has a population 92,063 with 50.9% AA, 34% Hispanic, 13.8% White and 1.1% Asian. Both cities have significant poverty and are in the lowest 3% of the states annual per capita income. We investigated the effect of the change by the USPTSF PSA guidelines in 2012 on the detection and mortality of prostate cancer in these two underserved urban centers. METHODS: NJ State Cancer Registry was used to compare prostate cancer detection and mortality rates in from 2008- 2019. We specifically compared annual rates in Newark/ Essex County and Trenton/ Mercer County. The cohort of patients from 2008-2012 was compared to the cohort from 2013-2019 to determine if there was a change due to PSA screening RESULTS: The incidence of prostate cancer in Trenton was 1667 and Newark 3161 from 2008-2012. Age adjusted rate of prostate cancer was 166.2 whites and 303.7 AA in Trenton. The age adjusted rate of prostate cancer was 161.5 for whites and 221.5 for AA in Newark. The prostate cancer specific mortality was 21.1 for whites and 57.6 for AA in Trenton from 2008-2012. The prostate cancer specific mortality was 16.6 for whites and 48.3 for AA in Newark. CONCLUSIONS: Statewide rate of prostate cancer deaths in both white and AA has decreased in New Jersey since the initiation of the USPTSF guideline change in 2012. This decrease in mortality has been observed in both underserved Trenton and Newark. Better access to healthcare via Medicaid expansion and opportunities for earlier or more effective treatment may be areas that have improved outcomes and warrant further study. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e134 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Thomas Hwang More articles by this author David Ali More articles by this author Gabriel Fernandez More articles by this author Courtney Berg More articles by this author Evan Kovac More articles by this author Amjad Alwaal More articles by this author Robert Weiss More articles by this author Expand All Advertisement PDF downloadLoading ...